Electrochemical biosensor for direct determination of percentage of glycated hemoglobin

• US 8,673,646 B2
• Filed: 05/13/2009
• Issued: 03/18/2014
• Est. Priority Date: 05/13/2008
• Status: Expired due to Fees

• Current Assignee: Diazyme Laboratories, Inc. (General Atomics, Inc.)
• Original Assignee: General Atomics, Inc.
• Inventors: Yuan, Chong-Sheng, Blue, Neal K., Datta, Abhijit, Liu, Limin, Fang, Lei
• Primary Examiner(s): Ball, J. Christopher
• Application Number:
  US12/465,143
• Publication Number:
  US 20100025264A1
• Time in Patent Office: 1,770 Days
• Field of Search: 20440301-40315, 205/777.5, 205/792, 435/14, 435/25, 436/63, 436/66, 436/67
• US Class Current: 436/67
• CPC Class Codes: C12Q 1/005 involving specific analytes or enzymes including groups of enzymes, e.g. oxydases; C12Q1/004 takes precedence
• CPC Class Codes: G01N 2333/906 acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)
• CPC Class Codes: G01N 33/5438 Electrodes
• CPC Class Codes: G01N 33/723 Glycosylated haemoglobin

Abstract

The invention provides electrochemical biosensors for direct determination of percentage of glycated hemoglobin in blood samples without the need of a separated measurement of total hemoglobin content in blood samples. The invention provides methods for using the electrochemical biosensors.

Claims

1. A method of measuring percentage of glycated hemoglobin (HbA1c) in a sample, comprising:

a) applying a blood sample to a sample receiving well of an electrode device, wherein the blood sample has been treated with

     1) a lysing buffer which releases hemoglobin from red blood cells in the blood sample;

     2) a first oxidizing agent which selectively oxidizes a low molecular weight reducing substance

     3) a second oxidizing agent which selectively oxidizes a high molecular weight reducing substance, and

     4) a protease which digests glycated hemoglobin into glycated peptides or glycated amino acids;

wherein the electrode device comprises;

i) an electrode support;

ii) a working electrode placed on the electrode support, wherein a fructosyl amino acid oxidase is placed on or near the working electrode;

iii) a counter electrode placed on the electrode support;

iv) a reference electrode placed on the electrode support, wherein the working, counter and reference electrodes are spaced from each other;

wherein the working electrode and/or the counter electrode further comprise a catalyst which catalyzes the redox reaction of hydrogen peroxide; and

v) an insulation/covering layer defining an enclosed space over the working electrode, the counter electrode, and the reference electrode, wherein said insulation/covering layer forms a well for receiving a sample, wherein the sample well is located on the electrodes or near the electrodes;

wherein (i) the second oxidizing agent is a tetrazolium salt which is 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt or 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt;

(ii) the fructosyl amino acid oxidase comprises the amino acid sequence of SEQ ID NO;

1;

or (iii) the protease generates a glycated peptide from about 2 to about 30 amino acid residues;

b) applying an electrical potential between the working electrode and the reference electrode suitable for monitoring the hydrogen peroxide generated from the fructosyl amino acid oxidase-catalyzed reaction; and

c) measuring an electrical current between the working electrode and the counter electrode or a charge passed at the working electrode;

whereby the percentage of glycated hemoglobin in the sample is determined based on the measured current or charge as compared to a reference without measuring the total hemoglobin in the blood sample separately.

2. The method of claim 1, wherein the hydrogen peroxide generated by the fructosyl amino acid oxidase-catalyzed reaction is electrochemically detected directly or indirectly via a mediator or a catalyst.

3. The method of claim 1, wherein the electrical potential is applied between the working electrode and the reference electrode in a time delayed manner.

4. The method of claim 1, wherein the reference is a calibration curve.

5. The method of claim 1, wherein the electrode device further comprises a capillary-fill channel for receiving a sample through capillary action, wherein one end of the channel is in contact with the working electrode.

6. The method of claim 1, wherein the working electrode and the counter electrode further comprise a mediator which shuttles electrons between the hydrogen peroxide generated from said fructosyl amino acid oxidase-catalyzed reaction and the working electrode to create a current representative of the amount of the glycated hemoglobin in the sample.

7. The method of claim 6, wherein the mediator comprises one or more agents selected from the group consisting of ferrocene, Prussian Blue, metal phthalocyonine, and tetrathiafulvalene (TTF).

8. The method of claim 1, wherein the catalyst comprises one or more agents selected from the group consisting of Ir-carbon, Rh-carbon, and Ru-carbon.

9. The method of claim 8, wherein said Ir-carbon, Rh-carbon, and Ru-carbon are nanoparticles.

10. The method of claim 1, wherein the fructosyl amino acid oxidase is formulated in a matrix and is placed on or near the working electrode.

11. The method of claim 10, wherein the matrix comprises an enzyme immobilizing agent and a thickening polymer.

12. The method of claim 1, wherein the electrode device further comprises a sample transfer path between said sample well and said working electrode.

13. The method of claim 1, wherein the working electrode and/or the counter electrode comprise a metallized carbon selected from the group consisting of Ir-carbon, Rh-carbon, and Ru-carbon.

14. The method of claim 13, wherein Ir-carbon, Rh-carbon, and Ru-carbon are nanoparticles.

15. The method of claim 1, wherein the reference electrode is Ag/AgCl.

16. The method of claim 1, wherein the electrodes are screen-printed using thick film technology or using thin film lithography.

17. The method of claim 1, wherein the first oxidizing agent is selected from the group consisting of Dess-Martin periodinane, N-ethyl maleimide, sodium iodoacetate, sodium periodate, and Chloramine-T.

18. The method of claim 1, wherein the tetrazolium salt is 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt or 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt.

19. The method of claim 1, wherein the fructosyl amino acid oxidase comprises the amino acid sequence of SEQ ID NO:

1.

20. The method of claim 1, wherein the protease generates a glycated peptide from about 2 to about 30 amino acid residues.

21. A method of measuring percentage of glycated hemoglobin (HbA1c) in a sample, comprising:

a) applying a blood sample to a sample receiving well of an electrode device;

wherein the electrode device comprises;

i) an electrode support;

ii) a working electrode placed on the electrode support, wherein a fructosyl amino acid oxidase is placed on or near the working electrode;

iii) a counter electrode placed on the electrode support;

iv) a reference electrode placed on the electrode support, wherein the working, counter and reference electrodes are spaced from each other;

wherein the working electrode and/or the counter electrode further comprise a catalyst which catalyzes the redox reaction of hydrogen peroxide; and

v) an insulation/covering layer defining an enclosed space over the working electrode, the counter electrode, and the reference electrode, wherein said insulation/covering layer forms a well for receiving a sample, wherein the sample well is located on the electrodes or near the electrodes, and contains a first oxidizing agent which selectively oxidizes a low molecular weight reducing substance, a second oxidizing agent which selectively oxidizes a high molecular weight reducing substance, one or more proteases which digest glycated hemoglobin into glycated peptides or glycated amino acids, and a detergent that lyses red blood cells in a blood sample and releases hemoglobin; and

vi) a sample transfer path between said sample well and said working electrode;

wherein (i) the second oxidizing agent is a tetrazolium salt which is 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt or 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt;

(ii) the fructosyl amino acid oxidase comprises the amino acid sequence of SEQ ID NO;

1;

or (iii) the protease generates a glycated peptide from about 2 to about 30 amino acid residues;

b) applying an electrical potential between said working electrode and said reference electrode suitable for monitoring the hydrogen peroxide generated from the fructosyl amino acid oxidase-catalyzed reaction; and

c) measuring an electrical current between the working electrode and the counter electrode or a charge passed at the working electrode;

whereby the percentage of glycated hemoglobin in the sample is determined based on the measured current or charge as compared to a reference without measuring the total hemoglobin in the blood sample separately.

22. The method of claim 21, wherein the hydrogen peroxide generated by the fructosyl amino acid oxidase-catalyzed reaction is electrochemically detected directly or indirectly via a mediator or a catalyst.

23. The method of claim 21, wherein the electrical potential is applied between the working electrode and the reference electrode in a time delayed manner.

24. The method of claim 21, wherein the reference is a calibration curve.

25. The method of claim 21, wherein the working electrode and the counter electrode further comprise a mediator which shuttles electrons between the hydrogen peroxide generated from said fructosyl amino acid oxidase-catalyzed reaction and the working electrode to create a current representative of the amount of the glycated hemoglobin in the sample.

26. The method of claim 25, wherein the mediator comprises one or more agents selected from the group consisting of ferrocene, Prussian Blue, metal phthalocyonine, and tetrathiafulvalene (TTF).

27. The method of claim 21, wherein the catalyst comprises one or more agents selected from the group consisting of Ir-carbon, Rh-carbon, and Ru-carbon.

28. The method of claim 27, wherein said Ir-carbon, Rh-carbon, and Ru-carbon are nanoparticles.

29. The method of claim 21, wherein the fructosyl amino acid oxidase is formulated in a matrix and is placed on or near the working electrode.

30. The method of claim 29, wherein the matrix comprises an enzyme immobilizing agent and a thickening polymer.

31. The method of claim 21, wherein the working electrode and/or the counter electrode comprise a metallized carbon selected from the group consisting of Ir-carbon, Rh-carbon, and Ru-carbon.

32. The method of claim 31, wherein Ir-carbon, Rh-carbon, and Ru-carbon are nanoparticles.

33. The method of claim 21, wherein the reference electrode is Ag/AgCl.

34. The method of claim 21, wherein the electrodes are screen-printed using thick film technology or using thin film lithography.

35. The method of claim 21, wherein the first oxidizing agent is selected from the group consisting of Dess-Martin periodinane, N-ethyl maleimide, sodium iodoacetate, sodium periodate, and Chloramine-T.

36. The method of claim 21, wherein the tetrazolium salt is 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt or 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt.

37. The method of claim 21, wherein the fructosyl amino acid oxidase comprises the amino acid sequence of SEQ ID NO:

1.

38. The method of claim 21, wherein the protease generates a glycated peptide from about 2to about 30 amino acid residues.

39. A method of measuring percentage of glycated hemoglobin (HbA1c) in a sample, comprising:

a) applying a blood sample to a working electrode of an electrode device, wherein the blood sample has been treated with

     1) a lysing buffer which releases hemoglobin from red blood cells in the blood sample;

     2) a first oxidizing agent which selectively oxidizes a low molecular weight reducing substance if the first oxidizing agent is not placed on or near the working electrode, or a second oxidizing agent which selectively oxidizes a high molecular weight reducing substance if the second oxidizing agent is not placed on or near the working electrode, and

     3) a protease which digests glycated hemoglobin into glycated peptides or glycated amino acids;

wherein the electrode device comprises;

i) an electrode support;

ii) a working electrode placed on the electrode support, wherein a fructosyl amino acid oxidase is placed on or near the working electrode, and wherein a first oxidizing agent which selectively oxidizes a low molecular weight reducing substance or a second oxidizing agent which selectively oxidizes a high molecular weight reducing substance is placed on or near the working electrode;

iii) a counter electrode placed on the electrode support; and

iv) a reference electrode placed on the electrode support, wherein the working, counter and reference electrodes are spaced from each other;

wherein (i) the second oxidizing agent is a tetrazolium salt which is 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt or 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt;

(ii) the fructosyl amino acid oxidase comprises the amino acid sequence of SEQ ID NO;

1;

or (iii) the protease generates a glycated peptide from about 2 to about 30 amino acid residues;

b) applying an electrical potential between said working electrode and said reference electrode suitable for monitoring the hydrogen peroxide generated from the fructosyl amino acid oxidase-catalyzed reaction; and

c) measuring an electrical current between the working electrode and the counter electrode or a charge passed at the working electrode;

whereby the percentage of glycated hemoglobin in the sample is determined based on the measured current or charge as compared to a reference without measuring the total hemoglobin in the blood sample separately.

40. The method of claim 39, wherein the treated blood sample is pipetted onto the working electrode.

41. The method of claim 39, wherein the electrode device comprises the capillary-fill channel for receiving a sample through capillary action and one end of the channel is in contact with the working electrode, and wherein the treated blood sample is applied to the working electrode through a capillary-fill channel.

42. The method of claim 39, wherein the working electrode and the counter electrode further comprise a mediator which shuttles electrons between the hydrogen peroxide generated from said fructosyl amino acid oxidase-catalyzed reaction and the working electrode to create a current representative of the amount of the glycated hemoglobin in the sample.

43. The method of claim 42, wherein the mediator comprises one or more agents selected from the group consisting of ferrocene, Prussian Blue, metal phthalocyonine, and tetrathiafulvalene (TTF).

44. The method of claim 39, wherein the working electrode and/or the counter electrode further comprise a catalyst which catalyzes the redox reaction of hydrogen peroxide.

45. The method of claim 44, wherein the catalyst comprises one or more agents selected from the group consisting of Ir-carbon, Rh-carbon, and Ru-carbon.

46. The method of claim 45, wherein said Ir-carbon, Rh-carbon, and Ru-carbon are nanoparticles.

47. The method of claim 39, wherein the fructosyl amino acid oxidase is formulated in a matrix and is placed on or near the working electrode.

48. The method of claim 47, wherein the matrix comprises an enzyme immobilizing agent and a thickening polymer.

49. The method of claim 39, wherein the working electrode and/or the counter electrode comprise a metallized carbon selected from the group consisting of Ir-carbon, Rh-carbon, and Ru-carbon.

50. The method of claim 49, wherein Ir-carbon, Rh-carbon, and Ru-carbon are nanoparticles.

51. The method of claim 39, wherein the reference electrode is Ag/AgCl.

52. The method of claim 39, wherein the electrodes are screen-printed using thick film technology or using thin film lithography.

53. The method of claim 39, wherein the first oxidizing agent is selected from the group consisting of Dess-Martin periodinane, N-ethyl maleimide, sodium iodoacetate, sodium periodate, and Chloramine-T.

54. The method of claim 39, wherein the tetrazolium salt is 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt or 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium monosodium salt.

55. The method of claim 39, wherein the fructosyl amino acid oxidase comprises the amino acid sequence of SEQ ID NO:

1.

56. The method of claim 39, wherein the protease generates a glycated peptide from about 2 to about 30 amino acid residues.